NCT05022563 - Treatment Patterns and Bleeding Risk of Anticoagulants in Patients With Venous Thromboembolism in Korea | Biotech Hunter

Enrollment

55,759

Participants

Timeline

Start Date

August 31, 2021

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions

Venous Thromboembolism

Interventions

DRUG

Parenteral anticoagulant

Parenteral anticoagulant only

DRUG

Warfarin

Warfarin-based

DRUG

Apixaban

DRUG

Rivaroxaban

DRUG

Dabigatran

DRUG

Edoxaban

Trial Locations (2)

Seoul National University Bundang Hospital, Seongnam-si

Sungkyunkwan University, Suwon